Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirus sýkingar - veirueyðandi lyf til almennrar notkunar - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Íhuga ætti að opinbera leiðsögn á réttri notkun af veirum.

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - aprepitantum inn - hart hylki - 125 mg/80 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 10 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg /12,5 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - enalaprilum maleat - tafla - 5 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

les laboratoires servier* - perindoprilum arginín - filmuhúðuð tafla - 5 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

novartis healthcare a/s - ciclosporinum inn - innrennslisþykkni, lausn - 50 mg/ml

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - enalapril maleate - tafla - 10 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - enalaprilum maleat - tafla - 20 mg

Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - aprepitantum inn - hart hylki - 125 mg + 80 mg